Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Cancer|July 1, 1997
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsT H Douglas, T O Morgan, D G McLeod, et al.Cancer Research|June 5, 2001
Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in ChinaA P Chokkalingam, K A McGlynn, Y T Gao, et al.Cancer Research|October 4, 2000
Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in ChinaA W Hsing, Y T Gao, G Wu, et al.The Prostate|July 1, 1995
Pathology review in an early prostate cancer detection program: results from the American Cancer Society-National Prostate Cancer Detection ProjectF K Mostofi, G P Murphy, C Mettlin, et al.Urology|May 1, 1993
Staging of early prostate cancer: a proposed tumor volume-based prognostic indexD G Bostwick, S D Graham, P Napalkov, et al.Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1994
Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993G P Murphy, C Busch, P A Abrahamsson, et al.Cancer|January 1, 1996
The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection ProjectC Mettlin, G P Murphy, R J Babaian, et al.British Journal of Urology|April 1, 1991
Interpretation of biopsies of "normal" urothelium in patients with superficial bladder cancer. MRC Superficial Bladder Cancer Sub GroupB Richards, M K Parmar, C K Anderson, et al.Cancer|November 14, 1997
Observations on the early detection of prostate cancer from the American Cancer Society National Prostate Cancer Detection ProjectC J Mettlin, G P Murphy, R J Babaian, et al.Cancer|January 15, 1992
Prediction of prognosis in untreated stage A2 prostatic carcinomaJ L Mohler, A W Partin, J I Epstein, et al.Pageof 9